dc.contributor
Institut Català de la Salut
dc.contributor
[Olaso-Gonzalez G, Viña J] Department of Physiology, Faculty of Medicine, Universitat de València, Valencia, Spain. [Inzitari M] REFiT Barcelona Research Group, Parc Sanitari Pere Virgili, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Department of Health Sciences, Universitat Oberta de Catalonia, Barcelona, Spain. [Bellelli G] School of Medicine and Surgery, University of Milano-Bicocca and Acute Geriatric Unit, San Gerardo Hospital, Monza, Italy. [Morandi A] REFiT Barcelona Research Group, Parc Sanitari Pere Virgili, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Department of Rehabilitation and Aged Care, Fondazione Teresa Camplani, Hospital Ancelle, Cremona, Italy. [Barcons N] Medical Affairs, Nestlé Health Science, Vevey, Switzerland
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Olaso-Gonzalez, Gloria
dc.contributor.author
Barcons, Núria
dc.contributor.author
Viña, José
dc.contributor.author
Inzitari, Marco
dc.contributor.author
Morandi, Alessandro
dc.contributor.author
Bellelli, Giuseppe
dc.date.accessioned
2025-10-24T08:56:54Z
dc.date.available
2025-10-24T08:56:54Z
dc.date.issued
2022-02-25T13:44:30Z
dc.date.issued
2022-02-25T13:44:30Z
dc.identifier
Olaso‐Gonzalez G, Inzitari M, Bellelli G, Morandi A, Barcons N, Viña J. Impact of supplementation with vitamins B6, B12, and/or folic acid on the reduction of homocysteine levels in patients with mild cognitive impairment: A systematic review. IUBMB Life. 2022 Jan;74(1):74–84.
dc.identifier
https://hdl.handle.net/11351/7092
dc.identifier
10.1002/iub.2507
dc.identifier
000656282300001
dc.identifier.uri
http://hdl.handle.net/11351/7092
dc.description.abstract
Àcid fòlic; Hhomocisteïna; Deteriorament cognitiu lleu
dc.description.abstract
Ácido fólico; Homocisteína; Deterioro cognitivo leve
dc.description.abstract
Folic acid; Homocysteine; Mild cognitive impairment
dc.description.abstract
Hyperhomocysteinemia is an independent predictor of the risk for cognitive decline and may be a result of low levels of vitamins B12, B6, and folate. Previous findings suggest that adequate intake of these vitamins may reduce homocysteine levels. This review aimed to assess the effects of treatment with vitamins B6, B12, and/or folic acid in the homocysteine levels in patients with mild cognitive impairment (MCI). A systematic literature review was conducted in EMBASE, MEDLINE®, PsycINFO, and Cochrane Central Register of Controlled Trials. The research question was formulated using the Population, Intervention, Comparison, and Outcome (PICO) framework: in patients with MCI (P); what is the efficacy of vitamins B6, B12, and/or folic acid intake (I); compared with baseline values, and/or compared with controls (C); in reducing homocysteine levels from baseline (O). A total of eight primary studies with a total of 1,140 participants were included in the review. Four were randomized controlled trials, one was a quasi-controlled trial, and three were observational studies. All studies included folic acid in their intervention, seven vitamin B12, and four vitamin B6. Mean (SD) length of the intervention period was 18.8 (19.3) months, ranging from 1 to 60 months. All studies showed a statistically significant decrease in homocysteine levels in groups treated with vitamins B6, B12, and/or folic acid compared to controls, with a mean decline of homocysteine concentration of 31.9% in the intervention arms whereas it increased by 0.7% in the control arm. This review identified evidence of a reduction of plasma homocysteine levels in MCI patients taking vitamins B6, B12, and/or folic acid supplements, with statistically significant declines being observed after 1 month of supplementation. Findings support that supplementation with these vitamins might be an option to reduce homocysteine levels in people with MCI and elevated plasma homocysteine.
dc.description.abstract
Nestlé Health Science, Switzerland
dc.format
application/pdf
dc.format
application/pdf
dc.format
application/pdf
dc.format
application/pdf
dc.format
application/pdf
dc.format
application/pdf
dc.format
application/pdf
dc.relation
IUBMB Life;74(1)
dc.relation
https://doi.org/10.1002/iub.2507
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Trastorns de la cognició - Tractament
dc.subject
Vitamines B - Ús terapèutic
dc.subject
Avaluació de resultats (Assistència sanitària)
dc.subject
PSYCHIATRY AND PSYCHOLOGY::Mental Disorders::Neurocognitive Disorders::Cognition Disorders::Cognitive Dysfunction
dc.subject
CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Growth Substances::Nutrients::Micronutrients::Vitamins
dc.subject
Other subheadings::Other subheadings::/therapeutic use
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome
dc.subject
PSIQUIATRÍA Y PSICOLOGÍA::trastornos mentales::trastornos neurocognitivos::trastornos cognitivos::disfunción cognitiva
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::sustancias del crecimiento::nutrientes::micronutrientes::vitaminas
dc.subject
Otros calificadores::Otros calificadores::/uso terapéutico
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento
dc.title
Impact of supplementation with vitamins B6, B12, and/or folic acid on the reduction of homocysteine levels in patients with mild cognitive impairment: A systematic review
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
